This study is in progress, not accepting new patients
A Study in Recurrent Glioblastoma (GB)
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at UCSF
- Dates
- study startedcompletion around
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Eli Lilly and Company
- ID
- NCT01582269
- Phase
- Phase 2 research study
- Study Type
- Interventional
- Participants
- Expecting 180 study participants
- Last Updated